Vmbook Online ordering

Alseres Pharmaceuticals Inc

Sure, I can assist you with that. Alseres Pharmaceuticals, Inc. was a clinical-stage biopharmaceutical company that focused on developing and commercializing therapeutic products for the treatment of cancer and rare diseases. The company was listed on the NASDAQ stock exchange under the ticker symbol "ALSE."

However, I must inform you that Alseres Pharmaceuticals, Inc. was acquired by Inceptio Medical Belgium BVBA, a subsidiary of Inceptio Therapeutics, Inc., in October 2020. As a result, Alseres is no longer a publicly traded company, and its stock is no longer listed on NASDAQ.

But, here's some general information about the company when it was still publicly traded:

* Alseres Pharmaceuticals, Inc. was incorporated in Delaware in 1995.

* The company's pipeline included several drug candidates in various stages of clinical development, including alseres lenalidomide (formerly known as ALS-157553), a drug for the treatment of hematological malignancies, including multiple myeloma and B-cell lymphoma; and AL-0161972, a drug-device combination product for the treatment of acute pain.

* Alseres Pharmaceuticals, Inc. had a partnership with Fresenius Kabi Oncology Limited for the development and commercialization of its product candidates.

* The company's fiscal year ended on December 31.

Please note that since the company is no longer publicly traded, the information I provided may no longer be up-to-date or accurate, and it's important to keep in mind that the company's pipeline and partnerships may have changed before its acquisition.